Health Boards
Following on from the bad news for Otezla (apremilast) Germany says Otezla gives no benefit to psoriasis patients today Celgene looks like taking another knock in the UK.
NICE (National Institute for Heath and Care Excellence) look set to say no to Otezla for England and Wales, (Scotland will be getting it however) it looks set to get rejected for use in England and Wales after not meeting cost effectiveness.
Don't ask me why Scotland gets preferential treatment, as far as I know it's a political thing.
*This report is made up from various pieces of information that have been passed on to me, I've not been able to find any official announcement as yet but it looks very likely this is going to happen.
NICE (National Institute for Heath and Care Excellence) look set to say no to Otezla for England and Wales, (Scotland will be getting it however) it looks set to get rejected for use in England and Wales after not meeting cost effectiveness.
Don't ask me why Scotland gets preferential treatment, as far as I know it's a political thing.
*This report is made up from various pieces of information that have been passed on to me, I've not been able to find any official announcement as yet but it looks very likely this is going to happen.